BIOTECHS FOR SALE ?

Investigación Financiera
  • Biotechs seem to be oversold and are struggling to find new funding
  • A new M&A cycle could help them to regain ground, if the regulator allows the sector to become more concentrated

Investigación Financiera

Artículos anteriores